Effects of Osteopathic Manipulative Treatment Associated With Pain Education and Clinical Hypnosis
Osteopathic Manipulative Treatment Associated With Education About Pain and Clinical Hypnosis and Their Repercussions on Pain and Disability in Chronic Low Back Pain - Randomized Clinical Trial
1 other identifier
interventional
40
1 country
1
Brief Summary
INTRODUCTION: Chronic low back pain (CLBD) is one of the major public health problems in the world. Given the complexity of the situation, complementary and alternative practices such as pain neuroscience education (PNE), clinical hypnosis (HC) and osteopathic manipulative treatment (OMT) are options for we manage these patients. OBJECTIVE: The aim of this study will be to evaluate the effects of OMT associated with PNE through HC on pain and disability in patients with CLBP compared to PNE and HC. MATERIALS AND METHODS: The study design will be a randomized clinical trial and 40 adults diagnosed with chronic low back pain will be recruited. Subjects will be randomized in two groups: the first group (G1) will be submitted to the PNE based on information from the book "Explain Pain" with hypnotic suggestions. Group 2 (G2) will receive PNE following the book "Explain Pain" with hypnotic suggestions associated with OMT. Volunteers will be evaluated by a blind researcher the interventions performed in the allocation of groups. The evaluation moments will be pre-intervention and immediately after the end of the last intervention for G1 and G2. Volunteers continued to be evaluated 4 weeks after completion of the protocols. Pain will be evaluated as the main outcome, being evaluated by the numerical pain scale. Pain will also be assessed by the pressure threshold using a pressure algometer device (Fnd-50, PIAB 50-n, Italy) in the lumbar region. Still as the main outcome, disability will be assessed using the Oswestry Disability Questionnaire. As secondary outcomes, the patient's global impression of improvement, central sensitization, biopsychosocial factors will be evaluated. The patient's global impression of improvement will be assessed using the Percentage of Improvement Scale with a score of -5 to +5; the Central Sensitization will be assessed using the Central Sensitization Questionnaire and the biopsychosocial factors using the Start Beck Toll questionnaire. In addition, the behavior of the autonomic nervous system will be evaluated through the Heart Rate Variability (HRV), which will be analyzed through linear methods, in the domains of time and frequency, and by geometric indices. The researcher/evaluator will be blinded to the allocation of intervention groups. Given the nature of the study, it is impossible to blind the researcher/therapist and volunteers.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable low-back-pain
Started Sep 2022
Shorter than P25 for not_applicable low-back-pain
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 4, 2021
CompletedFirst Posted
Study publicly available on registry
September 13, 2021
CompletedStudy Start
First participant enrolled
September 10, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 30, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
February 28, 2023
CompletedMarch 13, 2024
March 1, 2024
3 months
September 4, 2021
March 12, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Pain perception
The Pain suffered in the last week will be assessed by the Numerical pain scale, with a range of 0 - 10
T0= before the protocol; T1= until 24 hours after the end protocol; T2= four weeks after end protocols
Pain pressure threshold
Pain will be assessed by the pressure threshold using a pressure algometer device in the lumbar region. The assessment will be conducted specifically in the paravertebral muscles bilaterally at levels L1 to L5.
T0= before the protocol; T1= until 24 hours after the end protocol; T2= four weeks after end protocols
Disability
Disability will be assessed using the Oswestry Disability Questionnaire
T0= before the protocol; T1= until 24 hours after the end protocol; T2= four weeks after end protocols
Secondary Outcomes (3)
Patient's global impression of improvement
T0= before the protocol; T1= until 24 hours after the end protocol; T2= four weeks after end protocols
Central Sensitization and biopsychosocial factors
T0= before the protocol; T1= until 24 hours after the end protocol; T2= four weeks after end protocols
Heart Rate Variability
T0= before the protocol; T1= until 24 hours after the end protocol; T2= four weeks after end protocols
Study Arms (2)
Education in pain neurosciences and clinical hypnosis
EXPERIMENTALPain neuroscience education and clinical hypnosis
Education in pain neurosciences and clinical hypnosis plus Osteopathic manipulative treatment
ACTIVE COMPARATORPain neuroscience education and clinical hypnosis, associated with osteopathic manipulative treatment
Interventions
Will be performed education in pain neurosciences and clinical hypnosis, in 4 sessions during 4 weeks
Will be performed education in pain neurosciences and clinical hypnosis, and only for this group will be delivered osteopathic manipulative treatment, in 4 sessions during 4 weeks
Eligibility Criteria
You may qualify if:
- Nonspecific Low Back Pain for at least 3 months
- Score on the numerical pain scale of at least 3 points
You may not qualify if:
- Data from participants with less than 95% of sinus beats
- Participants that present increased symptoms in any stages of the study
- Patients who are undergoing concomitant physical therapy treatment, patients with contraindications to exercise, smokers/alcoholics, severe vertebral or neural pathologies, previous spine surgeries, cardiorespiratory disease, LBP as a secondary complaint, pregnancy, hearing problems, or illiteracy patients, not will are able to participate the protocol.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Anne Kastelianne
Presidente Prudente, São Paulo, Brazil
Related Publications (1)
Luchesi GLS, da Silva AKF, Amaral OHB, de Paula VCG, Jassi FJ. Effects of osteopathic manipulative treatment associated with pain education and clinical hypnosis in individuals with chronic low back pain: study protocol for a randomized sham-controlled clinical trial. Trials. 2022 Dec 30;23(1):1066. doi: 10.1186/s13063-022-07040-y.
PMID: 36581902DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- A simple randomized sequence will be created through the website www.randomization.com by a collaborator external to the researchers directly involved in the research. After the initial assessment, the researcher will access the randomization envelope and the participant will be allocated to 1 of the 2 treatment groups. The allocation will be hidden using opaque envelopes, sealed, and identified by number. The researcher/evaluator will be blinded to the allocation of intervention groups. Given the nature of the study, it is impossible to blind the researcher/therapist and volunteers
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- NETWORK
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 4, 2021
First Posted
September 13, 2021
Study Start
September 10, 2022
Primary Completion
November 30, 2022
Study Completion
February 28, 2023
Last Updated
March 13, 2024
Record last verified: 2024-03
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP
- Time Frame
- After one year from publication
- Access Criteria
- The request must be sent to the email address provided in the registration
The IPD will be shared by request